Definitive Contract 75N93020C00057
Award Date
9/30/20
Potential Completion Date
3/31/25
Potential Value
$2.9M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Chapel Hill, NC 27599, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The $3,398,047 award was made to the University of North Carolina at Chapel Hill (UNC-CH), doing business as the Office of Sponsored Research, to provide pre-clinical research services for infectious disease studies. This includes developing and refining animal models to evaluate potential...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the University of North Carolina at Chapel Hill (UNC-CH) to provide pre-clinical research services for infectious disease studies. The $2,221,849 contract is a Delivery Order under a larger $146.3 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract with UNC-CH that runs through July 2031. The IDIQ supports...
This is a $2,867,206.58 Delivery Order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of North Carolina at Chapel Hill (UNC-CH) to establish chronic bacterial infection models in mouse models of cystic fibrosis with Pseudomonas aeruginosa and Staphylococcus aureus. The contract is part of the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ contract vehicle. It is not a set-aside contract. UNC-CH is a prominent public...
This $1,573,207.29 delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of North Carolina at Chapel Hill (UNC-CH) to establish small animal models for screening medical countermeasures against the 2019 novel coronavirus (SARS-CoV-2). The contract is part of NIAID's 7-year, $146.3 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract for preclinical models of infectious diseases, which supports the...
This is a $271,640.00 firm fixed price Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to the University of North Carolina at Chapel Hill to perform Task A36 under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The award has an 18 month period of performance and does not utilize any set-aside designations. The University of North Carolina at Chapel...
This is a federal contract award to the University of North Carolina at Chapel Hill (UNC-CH) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The $563,541.00 contract is for screening vaccines and other biologics, and is a delivery order under the NIAID Preclinical Models of Infectious Diseases 2017-2024 contract vehicle. The contract has a total ceiling value of $2,254,164.00 and a period of performance...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $22,160.00 firm fixed-price purchase order to the University of North Carolina at Chapel Hill (UNC-CH) to provide Collaborative Cross (CC) mice for tick-borne disease studies being conducted at Rocky Mountain Laboratories (RML). The award has an ultimate completion date of October 15, 2024 and does not utilize a set-aside designation. This...
This is a $9,122.52 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of North Carolina at Chapel Hill (UNC-Chapel Hill) on August 12, 2015. The contract has an ultimate completion date of August 31, 2015 and was not set aside for any specific business category. UNC-Chapel Hill is a U.S. state government entity and institution of higher learning that...
The University of North Carolina at Chapel Hill, operating through its Office of Sponsored Research, has been awarded a $23,765 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, UNC will provide two batches of Collaborative Cross mice for tick-borne disease studies being conducted at the Rocky Mountain Laboratories in Hamilton, Montana. No subcontractors or set aside designations were specified. This...
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University under the NIAID Animal Models of Infectious Diseases 2010-2017 indefinite delivery indefinite quantity (IDIQ) contract. The $50,000 order is for Duke University to provide animal models of infectious diseases. No set-aside designation was used for this award. Duke University's Office of Research Administration Division serves as the prime...